Skip to main content

Big Data for Biomedical Research of Inflammatory Diseases

Cover image for Research Topic "Big Data for Biomedical Research of Inflammatory Diseases"
56kviews
Editorial20 September 2023
Editorial: Big data for biomedical research of inflammatory diseases

Inflammatory diseases, which include infectious and autoimmune diseases, malignant tumors, cardiovascular diseases, diabetes, and other chronic noninfectious diseases (NCDs) that fall under the category of inflammatory diseases, have emerged as a major threat to the health of the global population due to increasing urbanization, the aging process, and lifestyle changes (1,2).. These illnesses are becoming serious public health issues that pose a serious threat to human health and socioeconomic sustainability (3,4). New methods for disease prevention, diagnosis, and therapy will be developed by researching the mechanisms of inflammation occurrence and progression among these diverse diseases.Biomedical research of pharmacology and medicine in the 21st century is undergoing a change from conventional laboratory methods to new digital methods facilitated by the application of high-performance computing and big data analytic methods (5,6). The challenges of big data in biomedical research of pharmacology and medicine include big data capturing, analysis, information retrieval, transfer and visualisation, and information privacy protection (7). The research domains have encompassed the amount, variety, and velocity of big data in addition to other pertinent technology methods such high throughput data analysis, machine learning, natural language processing, medical knowledge representation, and healthcare decision making (8). When these techniques are used simultaneously on the same biospecimen, they produce information with astounding molecular accuracy that can be enhanced by various imaging data types, biosignals, or clinical records (9).Consequently, the title of this research topic "Big data for biomedical research in inflammatory diseases" was aimed to better provide the academic frontiers in computational methods for biomedical research of pharmacology and medicine in healthcare big Taken together, these above studies provide some of the interesting results and add new knowledge on the big data for biomedical research in inflammatory diseases. We are grateful to "Frontiers in Pharmacology" for giving us the opportunity to propose this research topic and invite a lot of authors in the related field. We also want to thank the editor for their quality control of the article, the reviewers for their valuable time and insightful suggestions, and the journal for providing this important platform.Key words: big data, biomedical research, healthcare, inflammation disease, multi-omic

1,807 views

3 citations

Integrating RNA-seq and scRNA-seq to explore the mechanism of macrophage ferroptosis associated with COPD
ORIGINAL RESEARCH
10 March 2023
Integrating RNA-seq and scRNA-seq to explore the mechanism of macrophage ferroptosis associated with COPD
Pengbei Fan, 4 more and Xiaodan Du
Aims: Our study focused on whether macrophages ferroptosis is associated with the pathogenesis of chronic obstructive pulmonary disease (COPD) or not. Main methods: We first identified macrophage module genes by weighted gene co-expression network analysis (WGCNA) in RNA sequencing (RNA-seq) date from COPD, and then identified macrophage marker genes by comprehensive analysis of single-cell RNA sequencing (scRNA-seq) data from COPD macrophages. There were 126 macrophage marker genes identified, and functional enrichment analyses indicated that ferroptosis pathway genes were significantly enriched. Secondly, we identified eight macrophage ferroptosis related genes and based on these eight genes, we performed co-expression analysis and drug prediction. Thirdly, two biomarkers (SOCS1 and HSPB1) were screened by the least absolute shrinkage and selection operator (LASSO), random forest (RF), and support vector machine-recursive feature elimination (SVM-RFE) and established an artificial neural network (ANN) for diagnosis. Subsequently, the biomarkers were validated in the dataset and validation set. These two biomarkers were then subjected to single gene-gene set enrichment analysis (GSEA) and gene set variation analysis (GSVA) analysis, and the ceRNA network was constructed. Finally, we carried out molecular validation with COPD models in vitro for cell counting kit-8 (CCK8) experiments, Western Blot and quantitative real-time PCR (qRT-PCR) analysis and transmission electron microscopy (TEM). Key findings: This study revealed the vital role of macrophage ferroptosis in COPD, and novel biomarkers (SOCS1 and HSPB1) may be involved in the pathogenesis of COPD by regulating macrophage ferroptosis. Significance: Taken together, our results suggest that targeting SOCS1 and HSPB1 could treat COPD by inhibiting macrophage ferroptosis.

11,946 views

24 citations

ORIGINAL RESEARCH
26 June 2023
HECT, UBA and WWE domain containing 1 represses cholesterol efflux during CD4+ T cell activation in Sjögren’s syndrome
Junhao Yin, 13 more and Lingyan Zheng

4,645 views

11 citations

ORIGINAL RESEARCH
15 February 2023
Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα in vivo and in vitro
Dequan Zeng, 1 more and Qiang Luo
Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα in vivo and in vitro
Celastrol, a triterpene derived from Thunder God Vine (Tripterygium wilfordii Hook f; Celastraceae), a traditional Chinese herb, has promising anticancer activity. The present study aimed to elucidate an indirect mechanism of celastrol-mediated alleviation of hepatocellular carcinoma (HCC) via gut microbiota-regulated bile acid metabolism and downstream signaling. Here, we constructed a rat model of orthotopic HCC and performed 16S rDNA sequencing and UPLC-MS analysis. The results showed that celastrol could regulate gut bacteria; suppress the abundance of Bacteroides fragilis; raise the levels of glycoursodeoxycholic acid (GUDCA), a bile acid; and alleviate HCC. We found that GUDCA suppressed cellular proliferation and induced the arrest of mTOR/S6K1 pathway-associated cell cycle G0/G1 phase in HepG2 cells. Further analyses using molecular simulations, Co-IP, and immunofluorescence assays revealed that GUDCA binds to farnesoid X receptor (FXR) and regulates the interaction of FXR with retinoid X receptor α (RXRα). Transfection experiments using the FXR mutant confirmed that FXR is essential for GUCDA-mediated suppression of HCC cellular proliferation. Finally, animal experiments showed that the treatment with the combination of celastrol/GUDCA alleviated the adverse effects of celastrol alone treatment on body weight loss and improved survival in rats with HCC. In conclusion, the findings of this study suggest that celastrol exerts an alleviating effect on HCC, in part via regulation of the B. fragilis-GUDCA-FXR/RXRα-mTOR axis.

5,301 views

34 citations

ORIGINAL RESEARCH
9 January 2023
Role of M1 macrophages in diabetic foot ulcers and related immune regulatory mechanisms
Yao Li, 6 more and Zhihui Dong
Role of M1 macrophages in diabetic foot ulcers and related immune regulatory mechanisms
Objectives Diabetes foot ulcer (DFUs) characterized of immune infiltration of M1 macrophages observed in foot skin, in which immune-associated genes (IRGs) play a prominent role; IRG's precise expression as well as any possible regulatory mechanisms that could be present in DFUs are yet unknown. Methods The analysis of the sequencing data of single cell RNA (scRNA) in foot skin of patients with DFUs was carried out, with the cluster marker genes of foot skin obtained from the ImmPort database screened out. IRG activity was assessed with AUCell software package. The IRGs of DFUs were explored by analyzing the batch sequencing data set of DFUs skin tissue. Human TFDB database was adopted to identify the relevant regulatory transcription factors (TFs). The STRING dataset was used to build the main TF's protein-protein interaction networks. Finally, WB and immunofluorescence methods were used to verify M1 macrophage-related immune regulators. Results There were 16 clusters found, such as SMC1, fibro, t-lympho, he fibro, vasendo, baselkera, diffkera, SMC2, M1 macro, M2 macro, sweet/seba, B-Lympho, Melanio, lymphendo, plasma and Schwann. M1 & M2 macrophages both had considerably higher AUC ratings than patients with DFUs compared to other sub-populations of cells. The proportion of M1 macrophages reached the highest in the non-healing group. According to analysis of scRNA and batch sequencing data by go and KEGG, DEGs were enriched in immune response. 106 M1 macroirgs were finally identified. 25 transcription factors were revealed associated with IRG expression. PPI network indicated the NFE2L2, REL, ETV6, MAF and NFIB as central transcription factors. Conclusions Based on the bio-informatics analysis of scRNA and high-throughput sequencing data, we concluded that M1 macrophages may serve as the influencing factor of DFUs nonunion. In addition, NFE2L2 could be involved in the regulation of IRG expression within M1 macrophages.

6,246 views

27 citations